The etiology of enterocutaneous fistula predicts outcome

Ochsner Journal

Volumn 13, Issue 4, 2013, Pages 507-511

  Redden, Meredith Holley ^a   Ramsay, Philip ^a   Humphries, Tim ^a   Fuhrman, George M ^b  

^a ATLANTA MEDICAL CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Intestinal fistula; Parenteral nutrition total; Postoperative complications

Indexed keywords

ALBUMIN; CREATININE; OCTREOTIDE;

ABDOMINAL CANCER; ABDOMINAL SURGERY; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; ENTEROCUTANEOUS FISTULA; ENTEROSTOMY; FEMALE; GASTROSTOMY; HUMAN; INJURY; INTESTINE ANASTOMOSIS; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MEDICAL HISTORY; MIDDLE AGED; NUTRITIONAL SUPPORT; PATHOGENESIS; PATIENT REFERRAL; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RELIABILITY; RETROSPECTIVE STUDY; SEX RATIO; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; TREATMENT OUTCOME; WOUND CARE;

EID: 84890370555     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg. 1983 Jul;7(4):446-450.
2. González-Pinto I, González EM. Optimising the treatment of upper gastrointestinal fistulae. Gut. 2001 Dec;49 Suppl 4:iv22-iv31.
3. Fisher S. Enterocutaneous fistula. In: Millikan KW, Saclarides TJ, eds. Common Surgical Disease: An Algorithmic Approach to Problem Solving. New York, NY: Springer-Verlag; 1998:164-167.
4. Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J Gastrointest Surg. 2006 Mar;10(3):455-464.
5. Visschers RG, Olde Damink SW, Winkens B, Soeters PB, van Gemert WG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008 Mar;32(3): 445-453.
6. Brenner M, Clayton JL, Tillou A, Hiatt JR, Cryer HG. Risk factors for recurrence after repair of enterocutaneous fistula. Arch Surg. 2009 Jun;144(6):500-505. Erratum in: Arch Surg. 2010 Jan; 145(1):10.
7. Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004 Dec;91(12):1646-1651.
8. Draus JM Jr, Huss SA, Harty NJ, Cheadle WG, Larson GM. Enterocutaneous fistula: are treatments improving? Surgery. 2006 Oct;140(4):570-576; discussion 576-578. Epub 2006 Sep 6.
9. McLean GK, Mackie JA, Freiman DB, Ring EJ. Enterocutaneous fistulae: interventional radiologic management. AJR Am J Roentgenol. 1982 Apr;138(4):615-619.
10. D'Harcour JB, Boverie JH, Dondelinger RF. Percutaneous management of enterocutaneous fistulas. AJR Am J Roentgenol. 1996 Jul;167(1):33-38.
11. Hoedema RE, Suryadevara S. Enterostomal therapy and wound care of the enterocutaneous fistula patient. Clin Colon Rectal Surg. 2010 Sep;23(3):161-168.
12. McNaughton V; Canadian Association for Enterostomal Therapy ECF Best Practice Recommendations Panel, Brown J, et al. Summary of best practice recommendations for management of enterocutaneous fistulae from the Canadian Association for Enterostomal Therapy ECF Best Practice Recommendations Panel. J Wound Ostomy Continence Nurs. 2010 Mar-Apr;37(2): 173-184.
13. Dearlove JL. Skin care management of gastrointestinal fistulas. Surg Clin North Am. 1996 Oct;76(5):1095-109.
14. Wainstein DE, Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg. 2008 Mar;32(3):430-435. Erratum in: World J Surg. 2008 Mar; 32(3):429.
15. Gunn LA, Follmar KE, Wong MS, Lettieri SC, Levin LS, Erdmann D. Management of enterocutaneous fistulas using negativepressure dressings. Ann Plast Surg. 2006 Dec;57(6):621-625.
16. Dorta G. Role of octreotide and somatostatin in the treatment of intestinal fistulae. Digestion. 1999;60 Suppl 2:53-56.
17. Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology. 2002 Jul-Aug; 49(46):1010-1012.
18. Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg. 1999 Jun;23(6):570-576.
19. Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg. 2006 Sep;93(9):1045-1055.
20. Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004 Nov;240(5): 825-831.
21. Palesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinal cancer. Dig Dis. 2003;21(3):198-213.
22. Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol. 2001 Sep;8(8):632-637.
23. Dalal KM, Gollub MJ, Miner TJ, et al. Management of patients with malignant bowel obstruction and stage IV colorectal cancer. J Palliat Med. 2011 Jul;14(7):822-828. Epub 2011 May 19.
24. Hisanaga T, Shinjo T, Morita T, et al. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol. 2010 Aug;40(8): 739-745. Epub 2010 Apr 21.
25. Schein M, Decker GA. Gastrointestinal fistulas associated with large abdominal wall defects: experience with 43 patients. Br J Surg. 1990 Jan;77(1):97-100.
26. Ramsay PT, Mejia VA. Management of enteroatmospheric fistulae in the open abdomen. Am Surg. 2010 Jun;76(6):637-639.